NEW YORK (WKOW) -- Pfizer Inc. is recalling close to one million birth control packets because the tablets may not contain enough active ingredients to prevent pregnancy, or the pills were packaged out of sequence
The recall involves 14 lots of Lo/Ovral®-28 (norgestrel and ethinyl estradiol) tablets and 14 lots of Norgestrel and Ethinyl Estradiol Tablets (generic).
As a result of this packaging error, the daily regimen for these oral contraceptives may be incorrect and could leave women without adequate contraception, and at risk for unintended pregnancy. These packaging defects do not pose any immediate health risks. However, consumers exposed to affected packaging should begin using a non-hormonal form of contraception immediately. Patients who have the affected product should notify their physician and return the product to the pharmacy.
For more information, check the FDA website for a full list of recalled lot numbers.